PT - JOURNAL ARTICLE AU - James J. Grannell AU - James R. Grannell TI - A Two-Region SEIR COVID-19 Epidemic Model for the Island of Ireland AID - 10.1101/2020.10.31.20223727 DP - 2020 Jan 01 TA - medRxiv PG - 2020.10.31.20223727 4099 - http://medrxiv.org/content/early/2020/11/04/2020.10.31.20223727.short 4100 - http://medrxiv.org/content/early/2020/11/04/2020.10.31.20223727.full AB - The island of Ireland consists of two countries, Ireland and Northern Ireland, which are separated by a land border. We develop a model for the COVID-19 epidemic which consists of two SEIR models, one for each country, coupled through border interaction terms. The model incorporates symptomatic and presymptomatic infectives, but not asymptomatic infectives, together with a simple isolation/quarantine model. The objective of the work is to explore how the two-region epidemic could evolve by examining selected regions of parameter space. In this context we examine the effect of the border status on evolution of the epidemic. We found that, even though the border interaction parameters are relatively small, the open border could significantly affect the course of the epidemic in some of the scenarios studied. We also looked for and found examples of sensitive dependence on several parameters.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB and/or ethics committee approvals were needed.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referenced are contained in the references quoted in the manuscript. No other data was referenced.